Care Delivery

This channel includes news on cardiovascular care delivery, including how patients are diagnosed and treated, cardiac care guidelines, policies or legislation impacting patient care, device recalls that may impact patient care, and cardiology practice management.

Thumbnail

Affordable Care Act Marketplace enrollment jumps 18% over last year

What's behind the jump in Affordable Care Act enrollment? HHS comments on this year's 18% jump. #ACA

Physicians are working fewer hours—unless they are mothers

Physicians are working fewer hours, with the average hours worked per week by physicians falling 7.6% between 2001 and 2021. However, physicians who are mothers are not seeing the same relief.

Tripledemic shortages: Walgreens, CVS limit sale of children’s medications

A wave of infections across the United States has led to a run on certain over-the-counter medications, and some retailers are limiting purchases to deal with the seasonal demand.

Why hospitals suffered financially in 2022—and a look ahead to 2023

Health Exec caught up with Erik Swanson, senior vice president of data and analytics at Kaufman Hall, to learn more about the underlying trends throughout 2022 and what hospitals are bracing for in 2023.

New discovery could reduce the risk of heart damage among cancer patients

Researchers have identified new details about the link between certain cancer therapies and heart complications. Could their work lead to key improvements in patient care?

There has been fear of a small number of patient who experience myocarditis after COVID vaccination, but a new study found it is safe in patients with prior heart damage. Image courtesy of Banner Health. #COVID19 #COVIDvaccination

COVID-19 vaccines prevented 3M deaths

An estimated 3.2 million excess deaths and 18.5 million hospitalizations have been prevented due to COVID-19 vaccines, the Commonwealth Fund found.

 

FDA adds diabetes medicine to drug shortage list

A diabetes treatment drug, Mounjaro, has been added to the Food and Drug Administration’s (FDA) list of drug shortages.

Thumbnail

No antithrombotic therapy after TAVR? New research highlights potential benefits

The study, published in JACC: Cardiovascular Interventions, focused on data from more than 3,500 TAVR patients.